Clinical trial on the Management of Bala Karappan in children using Kathalikantha Rasayanam (internal) and Karappan Ennai (external)

Clinical evaluation of Kathalikantha Rasayanam(Internal) and Karappan Ennai(External) in the management of Bala karappan in children

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043341

Enrollment

Registered

2022-06-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L209- Atopic dermatitis, unspecified

Interventions

Intervention1: Kathalikantha chooranam(internal) Karappan Ennai (external): Kathalikantha chooranam(internal) dosage 7 years-2g, 8-12 years- 3g with milk twice a day for 48 days and Karappan Ennai(ext

Eligibility

Inclusion criteria

Inclusion criteria: Children of both sexes in the age group of 7 to 12 years with symptoms of Erythema, Edema, Oozing, Itching, Crusting and scaling, Lichenified plaque and Willing to give Biological samples whenever necessary

Exclusion criteria

Exclusion criteria: Scabies Photodermatitis Fungal and parasitic skin infection Psoriasis Any other serious ailments

Design outcomes

Primary

Measure	Time frame
Reduction in the recurrence of the diseaseTimepoint: 1 year	—

Secondary

Measure	Time frame
Reduction in the recurrence of the diseaseTimepoint: fourty ninth day	—

Countries

India

Contacts

Public ContactDr M sridevi

National institute of Siddha

drsureshherbal@gmail.com9962571137

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026